1. Understand biologics' role in escalating health care expenditures in the U.S.
2. Compare and contrast the features of the small molecule-generic and biologic-biosimilar relationships.
3. Evaluate barriers to biosimilar market penetration and individual prescribing.
06/27/2019 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Garth W. Strohbehn, M.D., M.Phil.